STI(300416)2025-04-24 10:30Financial Performance - The company's operating revenue for Q1 2025 was ¥429,358,400.30, a decrease of 2.96% compared to ¥442,438,250.22 in the same period last year[5] - Net profit attributable to shareholders was ¥40,911,815.04, down 2.99% from ¥42,172,756.31 year-on-year[5] - Basic and diluted earnings per share were both ¥0.0804, a decrease of 3.02% from ¥0.0829 in the same period last year[5] - The net profit attributable to the parent company was approximately 42.17 million in the previous period, representing a decline of about 3.1%[24] - The total comprehensive income attributable to the parent company was approximately 40.76 million in the previous period, showing a slight increase of about 1.5%[24] Cash Flow - The net cash flow from operating activities was -¥99,953,240.83, representing a decline of 62.52% compared to -¥61,500,238.43 in the previous year[5] - The net cash flow from operating activities was negative at approximately -61.50 million in the previous period[26] - Cash inflow from operating activities totaled approximately 430.88 million, indicating a decrease of about 7.2%[26] - Cash outflow from operating activities was approximately 492.38 million, reflecting an increase of about 1.0%[26] - The net cash flow from financing activities was ¥146,670,476.33, an increase of 49.59% compared to ¥98,051,523.79 in the previous year[10] - The net cash flow from financing activities was approximately 98.05 million in the previous period, indicating a growth of about 49.3%[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,046,293,618.84, an increase of 0.26% from ¥5,033,229,938.15 at the end of the previous year[5] - Current liabilities total 1,536,379,973.43, a decrease from 1,543,378,455.29 in the previous period[20] - Non-current liabilities decreased to 354,763,478.96 from 379,711,589.18 in the previous period[21] - Total equity increased to 3,155,150,166.45 from 3,110,139,893.68 in the previous period[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 26,353[12] - The largest shareholder, Suzhou Testing Instrument, holds 31.93% of shares, totaling 162,401,460 shares[12] - The company has no preferred shareholders or significant changes in the top 10 shareholders due to margin trading[14] - The company has not disclosed any related party relationships among the top 10 shareholders[13] - The company has not reported any changes in restricted shares during the period[15] Other Income and Expenses - Other income increased by 50.66% to ¥4,557,663.94, primarily due to an increase in VAT deductions[9] - The company experienced a 95.17% improvement in investment income, with losses from joint ventures decreasing significantly[9] - Research and development expenses for the current period are 38,174,132.58, up from 35,076,322.80 in the previous period[23] Share Repurchase - The company plans to repurchase shares using between RMB 30 million and RMB 50 million, with a maximum price of RMB 15.00 per share[15] - A total of 2,499,400 shares were repurchased, accounting for 0.4915% of the total share capital, with a total transaction amount of RMB 30,083,675[15] - The company will implement the repurchased shares for employee stock ownership or incentive plans[15] Inventory and Receivables - Accounts receivable increased to RMB 1,296,357,769.37 from RMB 1,265,726,509.32[18] - Inventory has increased to 407,304,041.38 from 376,993,609.67 in the previous period[19] Comprehensive Income - The company reported a significant increase in other comprehensive income, rising 1197.14% to ¥430,527.09 due to changes in the value of other equity instruments and foreign currency translation differences[9]